需要臨床語境的頁面這個主題可能涉及檢查或影像解讀、神經系統疾病、手術、用藥或複雜基礎病語境。BioConst 只保留解釋性內容，不提供決策指南。
這是什麼
Osteogenesis imperfecta is a heritable fragility disorder, often involving type I collagen biology. Fractures cannot be reduced to calcium intake.[1]
大家可能感知到什麼
- People can have fractures with minimal or absent trauma, variable dentinogenesis imperfecta, and hearing loss in some forms.[1]
- Severity varies widely, so mild and severe cases should not be read as one pattern.[1]
- In children, fracture interpretation requires pediatric and genetic context.[2]
關鍵變數
Z-scorePediatric densitometry cannot diagnose osteoporosis by itself.[2]
BMDBMD can contribute to skeletal assessment but does not capture collagen quality alone.[1]
為什麼會發生
- Many cases involve COL1A1 or COL1A2 variants affecting type I collagen.[1]
- Other genetic forms exist, so a single collagen story does not cover every case.[1]
- Fragility comes from matrix quality, skeletal development, and fracture mechanics, not just density.[1]
臨床應對方向
- Clinical teams may coordinate genetics, orthopedics, rehabilitation, dental/hearing care, fracture care, and selected medication classes.[1]
- Mobility, pain, fracture prevention, and family counseling are often part of the care context.[1]
- BioConst does not interpret genetic tests or pediatric fracture histories.[1,2]
常見誤區
- Do not explain hereditary brittle bone as a calcium shortage.[1]
- Do not diagnose a child from DXA alone.[2]
- Normal BMD does not exclude matrix-quality problems.[1]